03/19/2020
4:18 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2020
1:47 PM | Arrowhead Pharmaceuticals (Subject)
FIRST MANHATTAN CO (Filed by)
| Form SC 13G/A
| |
01/28/2020
3:31 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEF 14A
| |
01/23/2020
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
4:00 PM | Arrowhead Pharmaceuticals (Filer)
| Form PRE 14A
| |
01/13/2020
4:13 PM | Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2020
5:35 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:33 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:31 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:10 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:08 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:02 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
3:54 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
3:51 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2019
5:35 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2019
8:55 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
12/04/2019
5:48 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2019
3:48 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
12/02/2019
3:02 PM | Arrowhead Pharmaceuticals (Filer)
| Form S-3ASR
| |
11/25/2019
3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/25/2019
3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2019
5:48 PM | Arrowhead Pharmaceuticals (Issuer)
Bradshaw Curt (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2019
5:44 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2019
5:45 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2019
6:32 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2019
6:31 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2019
9:56 AM | Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
09/27/2019
8:16 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2019
8:12 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
7:09 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019
3:03 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
6:19 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
5:12 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2019
6:01 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2019
5:57 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
4:44 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2019
3:12 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2019
4:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2019
5:57 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
3:55 PM | Arrowhead Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2019
2:17 PM | Arrowhead Pharmaceuticals (Filer)
| Form CT ORDER
| |
03/15/2019
4:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2019
7:42 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
6:08 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
6:32 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
7:12 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
7:09 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
8:22 AM | Arrowhead Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A
| |
02/13/2019
2:29 PM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/12/2019
7:58 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
7:35 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
3:50 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/07/2019
3:26 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2019
6:51 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
4:00 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2019
3:16 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A
| |
01/25/2019
3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEF 14A
| |
01/24/2019
7:53 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
7:46 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:02 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:00 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2019
7:24 PM | Arrowhead Pharmaceuticals (Issuer)
Li Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2019
7:18 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2019
2:12 PM | Arrowhead Pharmaceuticals (Subject)
OppenheimerFunds, Inc. (Filed by)
| Form SC 13G/A
| |
01/11/2019
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2019
4:12 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
7:18 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:16 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:15 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:13 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:08 PM | Arrowhead Pharmaceuticals (Issuer)
Li Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:58 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:55 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:53 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:49 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
4:20 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
4:15 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2018
6:40 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2018
4:18 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2018
3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/11/2018
3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2018
4:20 PM | Arrowhead Pharmaceuticals (Filer)
| Form S-3ASR
| |
11/26/2018
8:09 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
6:01 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2018
7:06 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2018
6:59 PM | Arrowhead Pharmaceuticals (Issuer)
Leone Peter Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2018
8:16 AM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2018
5:32 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
3:23 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2018
8:18 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2018
4:34 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
8:17 AM | Arrowhead Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G
| |
05/08/2018
3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2018
6:40 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
6:46 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2018
5:09 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2018
5:58 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
